The European Risk RA Registry
Optimal strategies for the management of people at risk of RA, both for symptom control and to delay or prevent progression to classifiable disease, remain poorly understood. In this MEDtalk MD Paul Studenic presents the successful effort to build a European Registry of at-risk people, to facilitate observational and interventional research. The goal is to provide an internationally unique resource for understanding the longitudinal development of RA.
